Science ❯Biotechnology

Drug Development

Drug Development Mergers and Acquisitions Pharmaceuticals Investment Strategies Acquisitions Mergers and Acquisitions Sales Projections Cancer Treatment Drug Development Acquisitions

Sanofi Seals $9.1 Billion Purchase of Blueprint Medicines

The addition of approved, late-stage immunology therapies triggers milestone-linked contingent value rights for Blueprint shareholders.

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics